MedTrace Logo

Evaluation of the Prognostic Value of T7 and T12 Slices on Mortality in Resuscitation Patients With ARDS Caused by SARS-COV2 Infection

NCT05594550 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-10-26

No results posted yet for this study

Summary

Sarcopenia is a risk factor for adverse outcome in critically ill patients. Sarcopenia might be estimated from muscle surface measure on tomodensitometry.

The purpose of the study is to identify if muscle surfaces measured on thoracic tomodensitometry are associated with mortality in patients with acute respiratory distress syndrome due to SARS-Cov-2.

Conditions

  • Acute Respiratory Distress Syndrom (SARS-Cov 2)

Interventions

OTHER

Data collection

Demographic data: Age, Sex, weight, height, main history and treatments. \- Biological data: CRP, PCT, albumin, pre-albumin

OTHER

analysis of thoracic scans

muscle area calculated on the T7 and T12 thoracic slices

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Dijon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2022-12-31
Completion
2022-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05594550 on ClinicalTrials.gov